| Financial Year |
March 31 2023 |
| Monetary Funds |
611,377,603.56 |
| Held-for-trading Financial Assets |
32,750,000.00 |
| Notes Receivable |
3,308,361.65 |
| Accounts Receivable |
314,170,539.97 |
| Advances to Suppliers |
122,488,685.11 |
| Other Receivables |
42,951,489.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
148,402,148.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
980,713.65 |
| Total Current Assets |
1,312,709,598.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
154,387,397.31 |
| Fixed Assetes |
464,255,951.55 |
| Under-construction Projects |
722,826.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
128,272,602.05 |
| R&D expenses |
1,132,898.72 |
| Goodwill |
274,362,384.03 |
| Long-Term Deferred and Prepaid Expenses |
161,245,369.26 |
| Deferred Income Tax Assets |
188,859,219.36 |
| Other Non-Current Assets |
28,685,945.40 |
| Sub-Total of Non-Current Assets |
1,930,322,841.09 |
| Total Assets |
3,243,032,439.99 |
| Short-Term Loans |
492,949,760.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
589,796,973.91 |
| Accounts Received In Advance |
10,054,387.75 |
| Employee Compensation Payable |
30,321,626.19 |
| Taxes Payable |
38,241,491.51 |
| Interest Payable |
-- |
| Dividend Payable |
26,495,864.04 |
| Other payables |
347,407,096.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
131,984,873.24 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,694,354,364.05 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,602,516.47 |
| Deferred Income Tax Liabilities |
8,397,880.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
348,754,899.56 |
| Total Liabilities |
3,043,109,263.61 |
| Paid-In Capital(Or Share Stock) |
419,536,980.00 |
| Capital Surplus |
407,497,283.44 |
| Surplus Reserve |
148,560,066.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-854,872,718.09 |
| Minority Stockholder's Interest |
84,805,735.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
115,117,441.27 |
| Owner's Equity（Stockholder's Equity） |
199,923,176.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,243,032,439.99 |
